Minoxidil and Clindagel drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Minoxidil (minoxidil) and Clindagel (clindamycin phosphate). Common drug interactions include bladder transitional cell carcinoma among females.
The phase IV clinical study analyzes what interactions people have when they take Minoxidil and Clindagel. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.
What is Minoxidil?
Minoxidil has active ingredients of minoxidil. It is often used in hair loss. eHealthMe is studying from 29,925 Minoxidil users. Check the latest studies of Minoxidil.
What is Clindagel?
Clindagel has active ingredients of clindamycin phosphate. eHealthMe is studying from 318 Clindagel users. Check the latest studies of Clindagel.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
22 people who take Minoxidil and Clindagel together, and have interactions are studied.
What are the common drug interactions of Minoxidil and Clindagel, by gender? *:
female:
- Bladder transitional cell carcinoma (types of bladder cancer)
- Second primary malignancy (after getting cure a cancer, a new cancer development)
male:
n/a
What are the common drug interactions of Minoxidil and Clindagel, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Bladder transitional cell carcinoma (types of bladder cancer)
- Second primary malignancy (after getting cure a cancer, a new cancer development)
What are the existing conditions these people have? *
- High Blood Pressure: 22 people, 100.00%
- Cardiac Failure: 19 people, 86.36%
* Approximation only. Some reports may have incomplete information.
Do you take Minoxidil and Clindagel?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Minoxidil and Clindagel:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Minoxidil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Clindagel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Minoxidil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Clindagel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Dubrey SW, VanGriethuysen J, Edwards CM, "A hairy fall: syncope resulting from topical application of minoxidil", BMJ case reports, 2015 Sep .
- Dubrey SW, VanGriethuysen J, Edwards CM, "A hairy fall: syncope resulting from topical application of minoxidil", BMJ case reports, 2015 Sep .
How the study uses the data?
The study uses data from the FDA. It is based on minoxidil and clindamycin phosphate (the active ingredients of Minoxidil and Clindagel, respectively), and Minoxidil and Clindagel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Diltiazem Hydrochloride cause Coronary Artery Occlusion? - 4 seconds ago
- Drug interactions of Carvedilol and Zelnorm - 6 seconds ago
- Tegretol and Restlessness for Women aged 30-39 - 8 seconds ago
- Tegretol and Agitation for Women aged 30-39 - 8 seconds ago
- Fludara and Hypoalbuminaemia for Girls aged 2-9 - 49 seconds ago
- Could Divalproex cause Oropharyngeal Pain? - 52 seconds ago
- Could Eligard cause Blood Glucose Decreased? - 58 seconds ago
- Bactrim and Pulmonary Oedema for Girls aged 10-19 - a minute ago
- Prednisone and Albuterol Sulfate drug interactions for men aged 60+ - a minute ago
- Could Ceftriaxone cause Gaze Palsy? - a minute ago